Chester County News and Community Website
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) opened fiscal 2026 with a surge in revenue and profit growth, raising its adjusted operating income outlook after completing a major oncology acquisition …
Cencora Delivers $85.9B Quarter, Lifts Profit Outlook Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) said its board of directors has elected Ellen Cooper as a new independent director, adding a veteran insurance executive and risk management leader …
Cencora Taps Lincoln Financial CEO for Board in Strategic Governance Move Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) will pull back the curtain on its financial performance early next month, announcing plans to release first-quarter fiscal 2026 results before markets open …
Cencora Sets Date to Reveal Q1 Results as Investors Brace for Early Look Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) said it has agreed to acquire the majority of the outstanding equity it does not already own in OneOncology, deepening its push into …
Cencora Bets Big on Oncology Platform in $5 Billion OneOncology Deal Read More CONSHOHOCKEN, PA — Cencora is expanding its third-party logistics network across the United States and Europe as the company positions itself to support rising demand for specialty pharmaceutical distribution and …
Cencora Makes Major Bet on Global Pharma Logistics With U.S.–Europe Expansion Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) reported a mixed finish to fiscal 2025, delivering strong full-year performance despite a significant fourth-quarter GAAP loss driven by impairment and integration charges. …
Cencora’s Earnings Surprise? Pharma Distributor Posts Big Gains—and a Rare Quarterly Loss Read More CONSHOHOCKEN, PA — IntrinsiQ Specialty Solutions, a division of Cencora, announced the expansion of its data and analytics offerings to include oncology biomarker data and new insights across multiple therapeutic …
IntrinsiQ Expands Data Capabilities to Advance Precision Medicine in Oncology and Specialty Care Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced it will release its financial results for the fourth quarter of fiscal 2025 on Wednesday, November 5, 2025, before the opening of …
Cencora to Announce Fourth Quarter Fiscal 2025 Results on November 5 Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) announced its Board of Directors has appointed D. Mark Durcan as Chairman, effective October 1, 2025. Durcan, currently the company’s Lead Independent Director, …
Cencora Names D. Mark Durcan Chairman of the Board Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) posted higher revenue and profits in its fiscal third quarter, driven by growth in both U.S. and international healthcare operations, and raised its full-year …
Cencora Lifts Earnings Outlook After Strong Q3 Performance Read More